National electronic prescribing network operator Surescripts has acquired clinical messaging software vendor Kryptiq Corp. for an undisclosed sum.

The companies have not formally announced the acquisition, but Luis Machuca, CEO of Beaverton, Ore.-based Kryptiq, has talked to Oregon newspapers about the deal.

The companies have been partners for some time. Surescripts previously held about 21 percent of Kryptiq after investing in the company in late 2010 and using Kryptiq’s technology to launch the exchange of clinical information over its e-prescribing network.

Now, selling out to Surescripts gives Kryptiq more resources and provides a solid return for investors, Machuca told The Oregonian. He expects to continue running Kryptiq and retain all 125 employees. The company anticipates 2012 revenue of about $25 million.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access